|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||
| Accounts receivable | ||||||||||||||||
| Other asset | ||||||||||||||||
| Other assets | ||||||||||||||||
| Investment as Collateral | ||||||||||||||||
| Prepaid Expenses | ||||||||||||||||
| Deferred charge | ||||||||||||||||
| Total current assets | ||||||||||||||||
| Right of use assets | ||||||||||||||||
| Property and equipment, net | ||||||||||||||||
| Investments | ||||||||||||||||
| Total assets | ||||||||||||||||
| Overdraft | ||||||||||||||||
| Accrued officer compensation | ||||||||||||||||
| Accounts payable | ||||||||||||||||
| Accrued liabilities | ||||||||||||||||
| Deferred Revenue Current | ||||||||||||||||
| Accrued interest | ||||||||||||||||
| Notes payable | ||||||||||||||||
| Lease liabilities -short term | ||||||||||||||||
| Carrying value | ||||||||||||||||
| Notes payable related parties | ||||||||||||||||
| Total current liabilities | ||||||||||||||||
| Deferred Revenue-noncurrent | ||||||||||||||||
| Non-Current Liabilities | ||||||||||||||||
| Lease liabilities long term | ||||||||||||||||
| Total Non-current Liabilities | ||||||||||||||||
| Total liabilities | ||||||||||||||||
| Commitments and contingencies | ||||||||||||||||
| Preferred stock value | ||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||
| Total preferred stock value | ||||||||||||||||
| Common stock, $0.00001 par value, 200,000,000 shares authorized and 60,745,926 and 52,789,000 shares issued and outstanding, respectively as of June 30, 2026 and December 31, 2025 | ||||||||||||||||
| Additional paid-in-capital | ||||||||||||||||
| Accumulated deficit | ||||||||||||||||
| Total stockholders' deficit | ||||||||||||||||
| Total liabilities and stockholders' deficit |
Loading...
